A Conservative Approach To Assess Warfarin Time-In-Therapeutic Ranges Among Nonvalvular Atrial Fibrillation Patients In An Integrated Healthcare Delivery System Setting In The U.S
Abstract
Authors
S. Deitelzweig M. Evans E. Hillson J. Trocio A. Bruno W. Tan M. Lingohr-Smith J. Lin